AMRX
NASDAQ · Pharmaceuticals
Amneal Pharmaceuticals Inc
$16.11
-0.10 (-0.62%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+24.40%
1Y
+103.54%
YTD
+27.25%
Open$16.21
Previous Close$16.21
Day High$16.40
Day Low$16.02
52W High$16.61
52W Low$7.67
Volume—
Avg Volume2.26M
Market Cap5.17B
P/E Ratio42.35
EPS$0.37
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.39
Above
SMA 200
$10.30
Above
RSI (14)
57.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+617.2% upside
Current
$16.11
$16.11
Target
$115.54
$115.54
$65.43
$115.54 avg
$156.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.97B | 2.67B | 607.96M |
| Net Income | 70.76M | 57.41M | 209.30M |
| Profit Margin | 2.4% | 2.3% | 34.4% |
| EBITDA | 606.69M | 519.61M | 317.16M |
| Free Cash Flow | — | — | 187.04M |
| Rev Growth | +10.9% | +10.9% | -4.4% |
| Debt/Equity | 136.58 | 136.58 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,102.08 | +0.32% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $231.29 | +1.27% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $115.48 | +1.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $25.08 | -0.52% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $54.70 | +1.30% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $75.89 | -3.58% | 12.5 | 33.00B |